RS5444, a novel PPARγ agonist, regulates aspects of the differentiated phenotype in nontransformed intestinal epithelial cells

Medicine & Life Sciences

• efatutazone 100%
• PPAR gamma 51%
• Epithelial Cells 33%
• Phenotype 27%
• Intestinal Mucosa 8%
• Cytoplasmic and Nuclear Receptors 8%
• Extracellular Matrix 7%
• 2,4-thiazolidinedione 5%
• Molecular Models 5%
• Rosiglitazone 5%
• matrigel 4%
• Oligonucleotide Array Sequence Analysis 4%
• Cell Cycle Checkpoints 4%
• Lipid Metabolism 4%
• Cell Adhesion 3%
• Small Intestine 3%
• Cell Movement 3%
• Cell Differentiation 3%
• Cell Cycle 3%
• Epithelium 3%
• Cell Proliferation 2%
• Apoptosis 2%
• Growth 2%

Chemical Compounds

• Physiological Role 56%
• Microarrays 49%
• Agonist 44%
• Oligonucleotide 40%
• Pharmacological Metabolism 35%
• Lipid 31%